相似文献
1
Unveiling the Future of Oncology and Precision Medicine through Data Science.
Int J Mol Sci. 2024 May 26;25(11):5797. doi: 10.3390/ijms25115797.
2
Enabling Precision Oncology Through Precision Diagnostics.
Annu Rev Pathol. 2020 Jan 24;15:97-121. doi: 10.1146/annurev-pathmechdis-012418-012735.
3
Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
Ann Oncol. 2016 Aug;27(8):1644-6. doi: 10.1093/annonc/mdw165. Epub 2016 Apr 26.
4
Genomic Medicine Takes the Stage, Again!
J Natl Compr Canc Netw. 2018 Jul;16(7):795. doi: 10.6004/jnccn.2018.0063.
5
Precision oncology: East meets West.
Int J Cancer. 2018 May 1;142(9):1734-1737. doi: 10.1002/ijc.31218. Epub 2018 Jan 4.
6
Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
Cell. 2018 Apr 19;173(3):535-539. doi: 10.1016/j.cell.2018.04.008.
7
Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.
Oncotarget. 2016 Aug 9;7(32):52493-52516. doi: 10.18632/oncotarget.9370.
8
Precision oncology: current and future platforms for treatment selection.
Trends Cancer. 2024 Sep;10(9):781-791. doi: 10.1016/j.trecan.2024.06.009. Epub 2024 Jul 19.
9
Pediatric oncology enters an era of precision medicine.
Curr Probl Cancer. 2017 May-Jun;41(3):194-200. doi: 10.1016/j.currproblcancer.2017.01.002. Epub 2017 Feb 1.
10
High-throughput sequencing in clinical oncology: from past to present.
Swiss Med Wkly. 2019 Apr 4;149:w20057. doi: 10.4414/smw.2019.20057. eCollection 2019 Mar 25.
引用本文的文献
1
The emergence of medical futures studies uncovers medicine and healthcare's untapped potential.
NPJ Digit Med. 2024 Dec 19;7(1):365. doi: 10.1038/s41746-024-01365-5.
本文引用的文献
1
Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO.
BMC Cancer. 2022 Feb 21;22(1):193. doi: 10.1186/s12885-022-09296-8.
2
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
N Engl J Med. 2021 Nov 11;385(20):1856-1867. doi: 10.1056/NEJMoa2112435. Epub 2021 Sep 18.
3
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol. 2021 May;22(5):609-619. doi: 10.1016/S1470-2045(21)00056-5. Epub 2021 Apr 9.
4
Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
Int J Mol Sci. 2020 Apr 23;21(8):2994. doi: 10.3390/ijms21082994.
5
Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival.
Int J Mol Sci. 2019 May 30;20(11):2655. doi: 10.3390/ijms20112655.
6
Network-based prediction of drug combinations.
Nat Commun. 2019 Mar 13;10(1):1197. doi: 10.1038/s41467-019-09186-x.
7
A survey of neural network-based cancer prediction models from microarray data.
Artif Intell Med. 2019 Jun;97:204-214. doi: 10.1016/j.artmed.2019.01.006. Epub 2019 Jan 30.
8
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.
Breast Cancer Res. 2019 Feb 22;21(1):30. doi: 10.1186/s13058-019-1118-z.
9
Precision Medicine: From Science To Value.
Health Aff (Millwood). 2018 May;37(5):694-701. doi: 10.1377/hlthaff.2017.1624.
10
The emerging clinical relevance of genomics in cancer medicine.
Nat Rev Clin Oncol. 2018 Jun;15(6):353-365. doi: 10.1038/s41571-018-0002-6.
Zotero 插件